文献速递糖尿病

反复低血糖的2型糖尿病小鼠模型下丘脑转录组学和蛋白质组学紊乱

Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
PubMed 文献 · Diabetologia · 2023-11-28

研究在2型糖尿病小鼠模型中比较急性与反复胰岛素诱导低血糖后的下丘脑改变,发现反复低血糖组血浆胰高血糖素显著低于急性组,下丘脑多种细胞类型转录与蛋白表达改变,提示低血糖感知受损和神经退行性特征。

要点

  • 反复低血糖组胰高血糖素分泌显著低于急性低血糖组。
  • 反复低血糖致下丘脑所有细胞类型转录谱改变及氧化磷酸化基因一致下调。
  • 反复低血糖下丘脑分子适应与皮层不同,涉及髓鞘形成和神经递质清除能力下降。

核心结论

  • 反复低血糖发作诱导影响所有下丘脑细胞类型及其相互作用的多种缺陷,提示神经元网络信号受损和低血糖感知失调,并呈现神经退行性疾病特征。
  • 与皮层相比,反复低血糖导致下丘脑特定的分子适应。

研究设计与样本

  • 高脂饮食喂养并低剂量链佐星处理的C57BL/6N小鼠暴露于一次(急性低血糖)或多次(反复低血糖)胰岛素诱导的低血糖发作。
  • 测量血浆胰高血糖素水平,获取下丘脑和皮层的单核RNA测序数据,以及下丘脑突触体组分的蛋白质组数据。

主要发现

  • 最终胰岛素注射后反复低血糖组与急性低血糖组血浆葡萄糖水平相似,但胰高血糖素分泌显著更低(急性组:94.5±9.2 ng/l [n=33];反复组:59.0±4.8 ng/l [n=37];p<0.001)。
  • 单核RNA测序显示急性与反复低血糖暴露小鼠下丘脑细胞亚群比例相似,但所有分析细胞类型均出现转录谱改变。
  • 反复低血糖暴露小鼠神经元中Avp、Pmch和Pcsk1n表达显著降低,Kcnq1ot1过表达最明显。
  • 差异表达基因的基因本体分析提示许多氧化磷酸化基因协调性降低及液泡H+-和Na+/K+-ATP酶表达减少,突触体组分蛋白质组分析大体证实这些观察。
  • 反复低血糖暴露小鼠少突胶质细胞基因表达 major 改变提示髓鞘形成减少,星形胶质细胞差异表达基因提示三联突触中神经递质清除能力降低,神经元和星形胶质细胞中多种基因表达改变提示淀粉样β蛋白生成和稳定性增加。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Repeated exposures to insulin-induced hypoglycaemia in people with diabetes progressively impairs the counterregulatory response (CRR) that restores normoglycaemia. This defect is characterised by reduced secretion of glucagon and other counterregulatory hormones. Evidence indicates that glucose-responsive neurons located in the hypothalamus orchestrate the CRR. Here, we aimed to identify the changes in hypothalamic gene and protein expression that underlie impaired CRR in a mouse model of defective CRR. METHODS: High-fat-diet fed and low-dose streptozocin-treated C57BL/6N mice were exposed to one (acute hypoglycaemia [AH]) or multiple (recurrent hypoglycaemia [RH]) insulin-induced hypoglycaemic episodes and plasma glucagon levels were measured. Single-nuclei RNA-seq (snRNA-seq) data were obtained from the hypothalamus and cortex of mice exposed to AH and RH. Proteomic data were obtained from hypothalamic synaptosomal fractions. RESULTS: The final insulin injection resulted in similar plasma glucose levels in the RH group and AH groups, but glucagon secretion was significantly lower in the RH group (AH: 94.5±9.2 ng/l [n=33]; RH: 59.0±4.8 ng/l [n=37]; p<0.001). Analysis of snRNA-seq data revealed similar proportions of hypothalamic cell subpopulations in the AH- and RH-exposed mice. Changes in transcriptional profiles were found in all cell types analysed. In neurons from RH-exposed mice, we observed a significant decrease in expression of Avp, Pmch and Pcsk1n, and the most overexpressed gene was Kcnq1ot1, as compared with AH-exposed mice. Gene ontology analysis of differentially expressed genes (DEGs) indicated a coordinated decrease in many oxidative phosphorylation genes and reduced expression of vacuolar H+- and Na+/K+-ATPases; these observations were in large part confirmed in the proteomic analysis of synaptosomal fractions. Compared with AH-exposed mice, oligodendrocytes from RH-exposed mice had major changes in gene expression that suggested reduced myelin formation. In astrocytes from RH-exposed mice, DEGs indicated reduced capacity for neurotransmitters scavenging in tripartite synapses as compared with astrocytes from AH-exposed mice. In addition, in neurons and astrocytes, multiple changes in gene expression suggested increased amyloid beta (Aβ) production and stability. The snRNA-seq analysis of the cortex showed that the adaptation to RH involved different biological processes from those seen in the hypothalamus. CONCLUSIONS/INTERPRETATION: The present study provides a model of defective counterregulation in a mouse model of type 2 diabetes. It shows that repeated hypoglycaemic episodes induce multiple defects affecting all hypothalamic cell types and their interactions, indicative of impaired neuronal network signalling and dysegulated hypoglycaemia sensing, and displaying features of neurodegenerative diseases. It also shows that repeated hypoglycaemia leads to specific molecular adaptation in the hypothalamus when compared with the cortex. DATA AVAILABILITY: The transcriptomic dataset is available via the GEO ( http://www.ncbi.nlm.nih.gov/geo/ ), using the accession no. GSE226277. The proteomic dataset is available via the ProteomeXchange data repository ( http://www.proteomexchange.org ), using the accession no. PXD040183.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Castillo-Armengol J, Marzetta F, Rodriguez Sanchez-Archidona A, et al. Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia. Diabetologia. 2023. PMID: 38017352. doi:10.1007/s00125-023-06043-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。